Kopran Share Price

Kopran Limited is an India-based pharmaceutical company. The Company is primarily engaged in the business of manufacturing of formulation (finished dosage form) and active pharmaceutical ingredients (API). Its formulations product categories include penicillin-based finished oral dosage forms and non-penicillin-based finished oral dosage forms. The Company's penicillin-based finished oral dosage forms include amoxycillin, ampicillin, cloxacillin, amoxy clauv, flucloxacillin, and phenoxy methyl penicillin. Its non-penicillin-based finished oral dosage forms include macrolides, cardiovascular, anti-helmentics, antihistamine, anti-diabetic, pain management, gastroenterology, and respiratory. It has a portfolio, producing over 100 dosage forms. These include tablets, capsules, dry powder, suspension and injectables. Its subsidiary, Kopran Research Laboratories Ltd, manufactures a range of APIs, including Atenolol and Sterile Carbapenems.As of 25 May 2026, Kopran share price is ₹188.48. The stock opened at ₹165.63, compared to its previous close of ₹163.18. During today's trading session, Kopran share price moved in the range of ₹165.20 to ₹195.81, with an average price of ₹180.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹165.20 and a high of ₹195.81. On the performance front, Kopran share price has increased by 26.88% over the last six months and is down 13.95% on a year-on-year basis.

The market capitalization of Kopran is ₹788 Crs, with a P/E ratio of 30.6 and a dividend yield of 1.84%.